about
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformationVascular calcifying progenitor cells possess bidirectional differentiation potentialsVEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.Assessment of atherosclerotic plaques in the rabbit abdominal aorta with interleukin-8 monoclonal antibody-targeted ultrasound microbubbles.The release of nitric oxide from S-nitrosothiols promotes angiogenesisAssessment of neovascularization within carotid plaques in patients with ischemic strokeLow vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesisTryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice.Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient miceThe therapeuatic effect of Endostar on soft carotid plaque neovascularization in patients with non-small cell lung cancer.Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery diseaseThe association between statin use and age related maculopathy.The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond.Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins.ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response.Ethanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice.Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth.Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a).Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression.Chemokines and atherosclerosisRole of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in AtherosclerosisSemaphorins and Their Receptors: From Axonal Guidance to AtherosclerosisUltrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse ModelHolistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease
P2860
Q24799326-A64ED409-EE0A-422B-B999-67831937FEF3Q28486087-1DF14B66-BBE9-48CE-A72E-F23E3952DFA2Q30432040-E701E39E-E401-464A-8CE7-28D16FAEC0D3Q30433214-92B8927B-85C4-4CF5-96BA-0EE225029037Q30457409-F10720D3-2789-4DAD-8A38-3D692A9B1A00Q33267286-5E60E215-01E8-4E5E-851E-9DECFB0AB0D3Q34389842-EA953452-E40D-4FB2-A0DA-11CADFE3E7B1Q34400309-9DF9BB40-244C-43EE-B012-CFDB35D68438Q34662158-D8193E07-CE24-48B1-A776-199D2DC67CA5Q34967612-209412DA-06C0-444D-88CC-BC262D1F9B5DQ35160832-BCDDA81C-EF64-47E0-8194-2A6EA7E330EFQ35581842-8D610294-325C-449F-8EEC-57398B69A5C0Q35591461-3B0C8030-426F-4FC6-8BA3-AC953C70576AQ35847328-356A2626-D583-4094-AE9C-3AB367C907CEQ36535574-E2B8544D-C5A9-4BB2-8186-351243456885Q36742493-0B0B7C1F-2B77-44E5-A631-3CFC13B68354Q37115200-83A7F2BE-2DC8-4482-9997-3808D837160DQ37641072-AE58807C-5AE5-400C-A131-508203F3A3E0Q37668312-0287A74B-58E6-4B4C-A959-35EFABB4592AQ38067325-528993CC-821E-4166-A104-51BD02A1FBD3Q38300473-1188FC53-7943-4714-97E7-514BE5A56380Q42115221-0D2BE93E-CBAC-4FC8-94EF-FE6F5F9334E5Q46669142-2DABC259-C954-467F-8757-ED03C7336249Q52886547-B06AC845-008F-4FE5-9807-701AD32A2CD5Q54219717-50B7CBBB-7A5C-47C1-AE89-76F8B338C9F6Q58246532-099E5406-F946-4D66-9741-3845589C3C06Q58551068-D0E48930-0038-406A-B659-D3703EEBB6B1Q58569848-00BD94E2-54B0-489C-86DA-CB7B7ADE0757Q58765933-943B2BA6-4C92-458A-97A3-239CE937C449Q58784996-328D82DD-AE0E-45FB-8941-BFB40FB60C75
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Plaque angiogenesis and atherosclerosis.
@ast
Plaque angiogenesis and atherosclerosis.
@en
Plaque angiogenesis and atherosclerosis.
@nl
type
label
Plaque angiogenesis and atherosclerosis.
@ast
Plaque angiogenesis and atherosclerosis.
@en
Plaque angiogenesis and atherosclerosis.
@nl
prefLabel
Plaque angiogenesis and atherosclerosis.
@ast
Plaque angiogenesis and atherosclerosis.
@en
Plaque angiogenesis and atherosclerosis.
@nl
P2860
P1476
Plaque angiogenesis and atherosclerosis.
@en
P2093
Moulton KS
P2860
P2888
P304
P356
10.1007/S11883-001-0065-0
P577
2001-05-01T00:00:00Z
P6179
1007843739